Bacterial Pneumonia Clinical Trials Bacterial Pneumonia RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Nabriva Initiates Second Phase 3 Clinical Trial of Lefamulin (“LEAP 2”) in Patients with Community-Acquired Bacterial Pneumonia (CABP)
VIENNA, Austria, and KING OF PRUSSIA, Pa., April 11, 2016 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents, with a focus on... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 11, 2016 Category: Pharmaceuticals Source Type: clinical trials

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
Condition:   Community Acquired PneumoniaInterventions:   Drug: Delafloxacin;   Drug: Moxifloxacin;   Drug: LinezolidSponsor:   Melinta Therapeutics, Inc.Not yet recruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2016 Category: Research Source Type: clinical trials

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial Pneumonia
Condition:   Community-acquired Bacterial PneumoniaInterventions:   Drug: Solithromycin;   Drug: Standard of CareSponsor:   Cempra PharmaceuticalsNot yet recruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2015 Category: Research Source Type: clinical trials